(98 days)
Not Found
No
The summary describes a physical medical device (support catheter) and its intended use for guiding other catheters and delivering fluids. There is no mention of software, algorithms, data processing, or any terms related to AI or ML. The performance studies focus on physical characteristics and equivalence to predicate devices.
No
The device is described as a "Support Catheter" intended to guide and support other laser catheters and provide a conduit for solutions, not to treat a disease or condition itself.
No
The intended use states the device is "intended to guide and support Spectranetics laser catheters during access of the vasculature and provide a conduit for the delivery of saline solutions or diagnostic contrast agents." It functions as a support and delivery system, not for diagnosing.
No
The device description clearly details physical components like radiopaque markers, a luer connector, and a hydrophilic coating, indicating it is a hardware device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the device is for guiding and supporting laser catheters, providing a conduit for saline or contrast agents, and accessing the vasculature. This is a therapeutic or interventional use, not a diagnostic one performed in vitro (outside the body) on biological samples.
- Device Description: The description focuses on the physical characteristics of a catheter designed for insertion into the body.
- Lack of IVD Indicators: There is no mention of analyzing biological samples, detecting specific substances, or providing diagnostic information based on laboratory tests.
IVD devices are used to examine specimens derived from the human body (like blood, urine, tissue) to provide information for diagnostic, monitoring, or compatibility purposes. This device does not fit that description.
N/A
Intended Use / Indications for Use
Cross-Pilot™ Turbo Elite® Support Catheters are intended to guide and support Spectranetics laser catheters during access of the vasculature and provide a conduit for the delivery of saline solutions or diagnostic contrast agents.
Product codes
DQY
Device Description
All models have 3 radiopaque markers spaced equally along the distal shaft to aid in estimating geometry within the vascular system. The most distal radiopaque marker is positioned within 3 mm of the distal catheter tip. A standard female luer is placed on the proximal end of each model. The catheter is coated with a lubricious, hydrophilic coating. Predicate devices of this type with similar intended uses have been classified into Class II. The support catheters are single-use and provided in sterile packaging.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
vasculature
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Comparative laboratory testing was conducted to assess physical dimensions, infusion rates and burst pressure. Test results show that the Spectranetics Cross-Pilot Turbo Elite Support Catheters are equivalent to the predicate devices with regard to safety, effectiveness, indication and performance.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1250 Percutaneous catheter.
(a)
Identification. A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.(b)
Classification. Class II (performance standards).
0
510(k) Summary
SUBMITTER INFORMATION
DEC 11 2008
- A. Company Name: Spectranetics Corporation, Inc.
- B. Company Address: 96 Talamine Court
Colorado Springs, Colorado 80907
- C. Company Phone: 719-633-8333 / 1-800-633-0960
- D. Company Facsimile: 719-447-2040
- E. Contact Person: Michael K. Handley
Vice President, Global Regulatory Affairs & Compliance
DEVICE IDENTIFICATION
- A. Device Trade Name: Spectranetics Cross-Pilot™ Turbo Elite® Support Catheter
- B. Device Common Name: Support Cathete
- C. Classification Name: Catheter, Percutaneous
- D. Device Class: Class II (per 21 CFR 870.1330)
- E. Device Code: DQY
CLAIMED EQUIVALENCE
Terumo 5Fr RadiFocus Optitorque (marketed as Glidecath) - K992051 Asahi Angiographic Catheters (marketed as Cook Slip-Cath XL) - K051561
DEVICE DESCRIPTION
| Model
(Ref.) | Size | Max. (OD)
Outer
Diameter | Working
Length | *Max
Pressure
psi (kPa) | Tip Shape |
|-----------------|------|--------------------------------|-------------------|-------------------------------|-----------|
| 518-068 | 5 Fr | 0.071" / 1.80 mm | 100 cm | 500 (3447) | Straight |
| 518-070 | 5 Fr | 0.071" / 1.80 mm | 125 cm | 500 (3447) | Straight |
| 518-069 | 5 Fr | 0.071" / 1.80 mm | 100 cm | 500 (3447) | Angled |
| 518-071 | 5 Fr | 0.071" / 1.80 mm | 125 cm | 500 (3447) | Angled |
Specifications:
- 75/25 Optiray 320 Contrast Sterile Saline
All models have 3 radiopaque markers spaced equally along the distal shaft to aid in estimating geometry within the vascular system. The most distal radiopaque marker is positioned within 3 mm of the distal catheter tip. A standard female luer is placed on the proximal end of each model. The catheter is coated with a lubricious, hydrophilic coating. Predicate devices of this type with similar intended uses have been classified into Class II. The support catheters are single-use and provided in sterile packaging.
1
Cross-Pilot Turbo Elite Support Catheters are intended to guide and support Spectranetics laser catheters during access of the vasculature and provide a conduit for the delivery of saline solutions or diagnostic contrast agents.
KO82959
BELGO, do
IDENTIFICATION OF PREDICATE DEVICES
Spectranetics Cross-Pilot Turbo Elite Support Catheters are equivalent to the Terumo 5Fr Radifocus Optitorque Angiographic Catheter (K992051), marketed at the 5Fr Radifocus Glidecath, and the Asahi Angiographic Catheters (K051561), marketed as Cook Slip-Cath XL, with regard to materials, basic design principles, construction, specifications, intended use and performance. Both are examples of a support catheter for guide wires, a common and familiar tool of cardiovascular interventionist.
COMPARISON TO PREDICATE DEVICES
Comparative laboratory testing was conducted to assess physical dimensions, infusion rates and burst pressure. Test results show that the Spectranetics Cross-Pilot Turbo Elite Support Catheters are equivalent to the predicate devices with regard to safety, effectiveness, indication and performance.
BIOCOMPATIBILITY, STERILIZATION, PACKAGING, AND BENCH TESTING
Cross-Pilot Turbo Elite Support Catheters are built from the same components and materials of construction as the predicate devices, already-marketed products. Biocompatibility of the finished Cross-Pilot Turbo Elite Support Catheters utilizing identical component materials have been confirmed in conformance with ISO 10993-1:2003, Biological Evaluation of Medical Devices. Device integrity and functionality were qualified and/or validated using samples produced under routine manufacturing conditions. An internal company protocol was prepared and executed in conformance with ANSI/AAMI/ISO 11135:1994, Medical Devices - Validation and Routine Control of Ethylene Oxide Sterilization. All Cross-Pilot Turbo Elite Support Catheters models meet or exceed both Spectranetics in-house requirements, and requirements listed in ISO 10555-1, Sterile, Single-use Intravascular Catheters - Part 1: General Requirements. Package integrity was initially validated in conjunction with sterilization studies.
TECHNILOGICAL CHARACTERISTICS
The Spectranetics Cross-Pilot Turbo Elite Support Catheters have the same technical characteristics as the Terumo 5Fr Radifocus Optitorque (GlideCath) and the Asahi Angiographic Catheters (Slip-Cath XL), the predicate devices. Both devices feature a stainless steel braided shaft for aided support and torque response and a tapered tip.
CONCLUSION
The Spectranetics Cross-Pilot Turbo Elite Support Catheters are substantially equivalent to the predicate devices.
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with its wings spread, clutching a caduceus in its talons. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the eagle.
Public Health Service
Food and Drug Administration 200 Corporate Boulevard Rockville MD 20850
Spectranetics Corporation, Inc. c/o Mr. Michael K. Handley Vice President Global Regulatory Affairs & Compliance 9965 Federal Drive Colorado Springs, CO 80921
DEC 1 1 2008
Re: K082559
Spectranetics Cross-Pilot™ Turbo Elite® Support Catheter Regulation Number: 21 CFR 870.1250 Regulation Name: Percutaneous Catheter Regulatory Class: Class II Product Code: DQY Dated: November 18, 2008 Received: November 19, 2008
Dear Mr. Handley:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 - Mr. Michael K. Handley
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometrics' (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Duna D. Vanes
Bram D. Zuckerman, M.D. ~Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Spectranetics
.spectranetics.com
570(k) #: K08 2559
Statement of Indication for Use
Device Name: Spectranetics Cross-Pilot™ Turbo Elite® Support Catheters
Indications for Use
Cross-Pilot™ Turbo Elite® Support Catheters are intended to guide and support Spectranetics laser catheters during access of the vasculature and provide a conduit for the delivery of saline solutions or diagnostic contrast agents.
Prescription Use XXXX
AND/OR
Over-The-Counter Use
(Part 21 CFR 801 Subpart D)
(21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
ina R. V. Ahmer
(Division Sian-Off) Division of Cardiovascular Devices
510(k) Number_K082559